Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT

User menu

Search

  • Advanced search
eNeuro
eNeuro

Advanced Search

 

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT
PreviousNext
Research ArticleNew Research, Cognition and Behavior

Terminal Dopamine Release Kinetics in the Accumbens Core and Shell Are Distinctly Altered after Withdrawal from Cocaine Self-Administration

Michael P. Saddoris
eNeuro 30 September 2016, 3 (5) ENEURO.0274-16.2016; https://doi.org/10.1523/ENEURO.0274-16.2016
Michael P. Saddoris
Department of Psychology & Neuroscience, University of Colorado Boulder, Boulder, CO 80309
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Michael P. Saddoris
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Schematic of experimental design, reinforced presses across the 14 d of self-administration training, and schematic of different metrics of DA release kinetics. A, Points in the release kinetics in relation to the peak DA release (i.e., point of greatest [DA] after stimulation). Half peak is the point at exactly half of peak concentration, Return to baseline (BL) is the point at which the [DA] was within a 95% confidence interval of the baseline, and T20 and T80 reflect 20% and 80% decrease in [DA] from peak, respectively. AUC was estimated by summing the [DA] in each 100-ms bin between stimulation and return to BL. B, Latency measures derived from the points of release and reuptake from A. Latency to peak, FWHH (i.e., latency from stimulation to half peak), and return to BL latency are relative to stimulation, whereas T20 and T80 latencies are relative to peak. C–E, Rates of change relative to points during release. Release velocity is the rate of increase in [DA] from stimulation to peak, Vmax is the rate of uptake between the peak and T20, and slope is the rate of uptake between T20 and T80.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    Placement of electrodes during recording in controls (top) or cocaine (bottom) rats. Black circles, core; gray circles, shell.

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    Distribution of peak [DA] amplitude from stimulation trials in the NAc core (control, black; cocaine, blue) and NAc shell (control, gray; cocaine, red). Peak [DA] responses for each stimulation were binned by 50-ms epochs from 0 to 1200 nm, while all stimulations that were greater than 1200 nm represented the final bin. Proportion reflected the number of stimulations in that bin as a proportion of all stimulations from that group. **Control core vs. control shell; §control core vs. cocaine core; @control shell vs. cocaine shell; p < 0.001 for relevant χ2.

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4.

    Representative color plots of stimulated DA release in NAc core (A and B) and NAc shell (C and D). E, Overlapped traces of DA elicited by electrical stimulation in core and shell of controls and cocaine-experienced subjects from the representative color plots in A–D.

  • Figure 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 5.

    Kinetic factors of DA release aligned by peak [DA] in control core (black squares), cocaine core (blue squares), control shell (gray circles), and cocaine shell (red circles) recordings. **Control core vs. control shell; Δcontrol core vs. both cocaines; §control core vs. cocaine core; @control shell vs. cocaine shell; ‡control Shell vs. both cocaines; p < 0.01 (Bonferroni-corrected α for multiple comparisons).

  • Figure 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 6.

    Average phasic DA release in the NAc core (A) and shell (B) of controls (black/gray) and cocaine self-administering rats (blue/red) in stimulation index–aligned bins. C, For each drug group and region, the proportion of cells (of all observations) in each stimulation index bin. Note log2 scale used to show the loss specifically of the low stimulation index observations in the cocaine groups. Peak [DA] (D), rise velocity (E), and Vmax (F) for treatment groups across stimulation intensity bins. **Control core vs. control shell; Δcontrol core vs. both cocaines; §control core vs. cocaine core; @control shell vs. cocaine shell; ‡control shell vs. both cocaines; p < 0.01 (Bonferroni-corrected α for multiple comparisons).

Tables

  • Figures
    • View popup
    Table 1.

    Peak-aligned pairwise comparisons (individual drug groups)

    p-values (t test)Core (control) vs. shell (control)Core (control) vs. core (cocaine)Shell (control) vs. shell (cocaine)
    Peak [DA], µm0. 10.20.40.80.10.20.40.80.10.20.40.8
    Peak0.870.020.970.320.030.001*0.070.660.810.420.940.03
    Frequency0.007*0.001*0.540.910.040.280.100.850.030.200.430.34
    AUC0.020.050.001*0.008*0.060.120.110.090.100.520.880.24
    Rise velocity<0.0001*<0.0001*<0.0001*0.004*0.002*<0.0001*0.008*0.070.0004*0.060.060.07
    Latency peak<0.0001*<0.0001*<0.0001*<0.0001*0.27<0.0001*0.120.003*<0.0001*0.020.220.53
    Vmax<0.0001*<0.0001*<0.0001*0.010.0008*<0.0001*0.020.080.630.520.530.36
    FWHH<0.0001*<0.0001*<0.0001*<0.0001*0.28<0.0001*0.150.003*<0.0001*0.140.670.93
    Slope (T20–T80)<0.0001*<0.0001*0.520.800.840.050.980.980.410.370.210.009*
    Baseline return0.0002*0.002*0.600.630.840.830.560.340.870.230.340.35
    T20 latency<0.0001*<0.0001*<0.0001*<0.0001*0.16<0.0001*0.12<0.0001*<0.0001*0.070.690.89
    T80 latency<0.0001*<0.0001*0.020.850.910.100.800.400.0006*0.870.410.08
    • Significance (p-value) of pairwise t tests at each peak bin (low [<0.1 μm DA], medium-low [0.1–0.2 μm DA], medium-high [0.2–0.4 μm DA], and high [0.4–0.8 μm DA]) between core control and shell control (left), core control and core cocaine (middle), and shell control and shell cocaine (right). Bold italics: *p < 0.01 (significant after Bonferroni correction); italics only: p < 0.05 (not significant after Bonferroni correction).

    • View popup
    Table 2.

    Peak-aligned pairwise comparisons (collapsed drug groups)

    p-values (t test)Core (control) vs. Shell (control)Core (control) vs. both cocainesShell (control) vs. both cocaines
    Peak [DA], µm0. 10.20.40.80.10.20.40.80.10.20.40.8
    Peak0.870.230.970.320.11<0.0001*0.280.260.860.240.490.13
    Frequency0.007*0.002*0.540.910.001*0.120.180.340.660.100.130.53
    AUC0.020.030.001*0.008*0.980.720.200.070.050.040.070.33
    Rise velocity<0.0001*<0.0001*<0.0001*0.004*<0.0001*<0.0001*<0.0001*<0.0001*0.070.080.820.17
    Latency peak<0.0001*<0.0001*<0.0001*<0.0001*0.0004*<0.0001*<0.0001*<0.0001*0.670.700.370.96
    Vmax<0.0001*<0.0001*<0.0001*0.01<0.0001*<0.0001*<0.0001*0.0008*0.050.200.480.35
    FWHH<0.0001*<0.0001*<0.0001*<0.0001*0.0004*<0.0001*<0.0001*<0.0001*0.320.470.120.64
    Slope (T20–T80)<0.0001*<0.0001*0.520.800.160.001*0.100.190.003*0.080.270.01
    Baseline return0.0002*0.002*0.600.630.160.300.490.870.007*0.050.990.70
    T20 latency<0.0001*<0.0001*<0.0001*<0.0001*0.0002*<0.0001*<0.0001*<0.0001*0.620.500.070.71
    T80 latency<0.0001*0.0006*0.020.850.0008*0.0001*0.007*0.001*0.060.250.270.16
    • Significance (p-value) of pairwise t tests at each peak bin (low [<0.1 μm DA], medium-low [0.1–0.2 μm DA], medium-high [0.2–0.4 μm DA], and high [0.4–0.8 μm DA]) between core control and shell control (left; repeated from Table 1), core control and average of both cocaine groups (core and shell; middle), and shell control average of both cocaine groups (core and shell; right). Bold italics: *p < 0.01 (significant after Bonferroni correction); italics only: p < 0.05 (not significant after Bonferroni correction).

    • View popup
    Table 3.

    Stimulation index–aligned pairwise comparisons (individual drug groups)

    p-values (t test)Core (control) vs. Shell (control)Core (control) vs. Core (cocaine)Shell (control) vs. Shell (cocaine)
    Stimulation index100300600120010030060012001003006001200
    Peak [DA]0.002*0.960.020.48<0.0001*0.003*0.0006*0.009*0.020.960.990.14
    Frequency0.970.002*0.461.000.240.730.870.140.120.370.761.00
    AUC0.010.980.210.450.0006*0.003*0.002*0.020.060.700.830.14
    Rise velocity0.0006*0.006*0.0003*<0.0001*0.0002*0.0002*0.006*0.0006*0.310.420.490.14
    Latency peak0.002*<0.0001*<0.0001*<0.0001*0.450.360.610.110.070.002*0.005*0.01
    Vmax0.002*0.003*<0.0001*0.0003*0.001*0.001*0.0002*0.004*0.01*0.780.780.16
    FWHH<0.0001*<0.0001*<0.0001*<0.0001*0.150.520.590.090.890.050.003*0.13
    Slope (T20–T80)0.001*0.810.004*0.260.009*0.030.002*0.090.004*0.770.680.10
    Baseline return0.260.740.960.910.070.010.110.030.560.280.100.88
    T20 latency<0.0001*<0.0001*<0.0001*<0.0001*0.020.320.090.070.300.100.280.31
    T80 latency0.006*0.250.020.0004*0.530.060.560.090.210.720.660.18
    • Significance (p-value) of pairwise t tests at each stimulation index bin (low [100–300], medium-low [300–600], medium-high [600–1200], and high [>1200]) between core control and shell control (left), core control and core cocaine (middle), and shell control and shell cocaine (right). Bold italics: *p < 0.01 (significant after Bonferroni correction); italics only: p < 0.05 (not significant after Bonferroni correction).

    • View popup
    Table 4.

    Stimulation index–aligned pairwise comparisons (collapsed drug groups)

    p-values (t test)Core (control) vs. shell (control)Core (control) vs. both cocainesShell (control) vs. both cocaines
    Stimulation index100300600120010030060012001003006001200
    Peak [DA]0.002*0.960.020.480.0008*0.003*0.0001*0.0003*0.360.370.410.07
    Frequency0.970.002*0.461.000.060.360.900.260.210.540.550.36
    AUC0.010.980.210.450.020.030.007*0.003*0.510.440.310.02
    Rise velocity0.0006*0.006*0.0003*<0.0001*<0.0001*<0.0001*<0.0001*<0.0001*0.430.270.920.69
    Latency peak0.002*<0.0001*<0.0001*<0.0001*0.005*0.002*0.0005*<0.0001*0.920.520.330.10
    Vmax0.002*0.003*<0.0001*0.0003*0.0002*<0.0001*<0.0001*<0.0001*0.070.550.790.30
    FWHH<0.0001*<0.0001*<0.0001*<0.0001*0.020.001*<0.0001*<0.0001*0.420.740.790.02
    Slope (T20–T80)0.001*0.810.004*0.260.002*0.006*<0.0001*0.001*0.007*0.590.700.21
    Baseline return0.260.740.960.910.990.300.600.390.250.280.740.03
    T20 latency<0.0001*<0.0001*<0.0001*<0.0001*0.0004*0.0007*<0.0001*<0.0001*0.090.700.600.0003*
    T80 latency0.006*0.250.020.0004*0.830.510.050.230.020.100.750.07
    • Significance (p-value) of pairwise t tests at each stimulation index bin (low [100–300], medium-low [300–600], medium-high [600–1200], and high [>1200]) between core control and shell control (left; repeated from Table 3), core control and average of both cocaine groups (core and shell; middle), and shell control average of both cocaine groups (core and shell; right). Bold italics: *p < 0.01 (significant after Bonferroni correction); italics only: p < 0.05 (not significant after Bonferroni correction).

Back to top

In this issue

eneuro: 3 (5)
eNeuro
Vol. 3, Issue 5
September/October 2016
  • Table of Contents
  • Index by author
Email

Thank you for sharing this eNeuro article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Terminal Dopamine Release Kinetics in the Accumbens Core and Shell Are Distinctly Altered after Withdrawal from Cocaine Self-Administration
(Your Name) has forwarded a page to you from eNeuro
(Your Name) thought you would be interested in this article in eNeuro.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
Terminal Dopamine Release Kinetics in the Accumbens Core and Shell Are Distinctly Altered after Withdrawal from Cocaine Self-Administration
Michael P. Saddoris
eNeuro 30 September 2016, 3 (5) ENEURO.0274-16.2016; DOI: 10.1523/ENEURO.0274-16.2016

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Share
Terminal Dopamine Release Kinetics in the Accumbens Core and Shell Are Distinctly Altered after Withdrawal from Cocaine Self-Administration
Michael P. Saddoris
eNeuro 30 September 2016, 3 (5) ENEURO.0274-16.2016; DOI: 10.1523/ENEURO.0274-16.2016
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Significance Statement
    • Introduction
    • Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
    • Synthesis
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Keywords

  • dopamine transporter
  • drug addiction
  • Michaelis–Menten
  • plasticity
  • ventral striatum
  • voltammetry

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

New Research

  • A Very Fast Time Scale of Human Motor Adaptation: Within Movement Adjustments of Internal Representations during Reaching
  • TrkB Signaling Influences Gene Expression in Cortistatin-Expressing Interneurons
  • Optogenetic Activation of β-Endorphin Terminals in the Medial Preoptic Nucleus Regulates Female Sexual Receptivity
Show more New Research

Cognition and Behavior

  • Calcium dynamics in hypothalamic paraventricular oxytocin neurons and astrocytes associated with social and stress stimuli
  • Touchscreen Response Precision Is Sensitive to the Explore/Exploit Trade-off
  • Eye Movements in Silent Visual Speech Track Unheard Acoustic Signals and Relate to Hearing Experience
Show more Cognition and Behavior

Subjects

  • Cognition and Behavior
  • Home
  • Alerts
  • Follow SFN on BlueSky
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Latest Articles
  • Issue Archive
  • Blog
  • Browse by Topic

Information

  • For Authors
  • For the Media

About

  • About the Journal
  • Editorial Board
  • Privacy Notice
  • Contact
  • Feedback
(eNeuro logo)
(SfN logo)

Copyright © 2025 by the Society for Neuroscience.
eNeuro eISSN: 2373-2822

The ideas and opinions expressed in eNeuro do not necessarily reflect those of SfN or the eNeuro Editorial Board. Publication of an advertisement or other product mention in eNeuro should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in eNeuro.